SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Pulmonary, Allergy and Critical Care Medicine

EDUCATION AND TRAINING



FELLOWSHIP


Joseph Bednash, MD

Post-Doctoral Scholar, ABIM Research Pathway
Division of Pulmonary, Allergy and Critical Care Medicine
UPMC Montefiore Hospital - NW628
3459 Fifth Avenue
Pittsburgh, PA 15213

Phone: 412-648-3098
Fax: 412-692-2260
Email: bednashjs@upmc.edu
Fellowship Coordinator: Brittany Manning


Bio

Dr. Joseph Bednash graduated from the University of Pittsburgh with a B.S. in Biology in 2007, Dr. Bednash remained in Pittsburgh for medical school, completing his M.D. in 2012. During his undergraduate medical education, he completed a scholarly project investigating the use of chemopreventative agents in head and neck cancer. Dr. Bednash subsequently joined the UPMC Internal Medicine Residency program and transitioned into Pulmonary and Critical Care fellowship in the research pathway. In his free time, Dr. Bednash enjoys camping, playing golf, or skiing.

Research interests

Dr. Bednash is currently a T32 postdoctoral scholar, his research focuses on the molecular regulation of the inflammasome with the goal of designing novel therapeutics for the treatment of inflammatory disease.  His research interests include Acute lung injury, Inflammatory signaling, and drug discovery.

Education

2004 - 2007: University of Pittsburgh, B.S., Biological Sciences
2008 - 2012: University of Pittsburgh School of Medicine, M.D.
2012-2014: UPMC Presby/Montefiore Internal Medicine Residency
2014-2015: University of Pittsburgh, Post-Doctoral Research Associate, Pulmonary Division
2015 – present : University of Pittsburgh, Pulmonary, Allergy & Critical Care Medicine Fellow

Publications

Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S, Watkins S, Joshi R, Thomas SM. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models. Head Neck. 2014 Mar; 36(3):385-92.

Wheeler SE, Morariu EM, Bednash JS, Otte CG, Seethala RR, Chiosea SI.  Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.  Clin Cancer Res. 2012 May 15;18(10):2850-60.

Leeman-Neill RJ, Seethala RR, Singh S, Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE, Joyce SC, Lingen MW, Neill DB, Grandis JR. Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma. Cancer Prev Res (Phila) 2011 Feb; 4 (2): 230 - 237.